SCHEMBL7903563

SCHEMBL7903563

C[C@@H]1CNc2c(cccc2[N+](=O)[O-])[C@H](C)N1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.39
NR4A1 P22736 1/20 0.38
MAPT P10636 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
ALDH1A1 P00352 1/20 0.36
MAPK1 P28482 1/20 0.36
KDM4E B2RXH2 1/20 0.36
GAA P10253 1/20 0.36
HTT P42858 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
TSHR P16473 2/20 0.36
PDE10A Q9Y233 1/20 0.36
GPR35 Q9HC97 1/20 0.35
HSD17B10 Q99714 1/20 0.34
CHRNB2 P17787 1/20 0.34
CHRNA4 P43681 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7903558 1.00 TDP1 (0.39) TDP1NR4A1MAPTMEN1KMT2A
SCHEMBL7903560 1.00 TDP1 (0.39) TDP1NR4A1MAPTMEN1KMT2A
SCHEMBL9381500 0.78 TDP1 (0.40) TDP1NR4A1MAPTMEN1KMT2A
SCHEMBL28095013 0.76 NR4A1 (0.40) TDP1NR4A1MAPTMEN1KMT2A
SCHEMBL27897234 0.75 TDP1 (0.40) TDP1NR4A1MAPTMEN1KMT2A
SCHEMBL9539807 0.74 PNMT (0.43) TDP1ALDH1A1SMN1; SMN2TSHRPDE10A
SCHEMBL27657163 0.74 SMN1; SMN2 (0.45) TDP1NR4A1MAPTMEN1KMT2A
SCHEMBL9539813 0.74 PNMT (0.43) TDP1ALDH1A1SMN1; SMN2TSHRPDE10A
SCHEMBL28813906 0.74 NR4A1 (0.39) TDP1NR4A1MAPTMEN1KMT2A
SCHEMBL6196688 0.73 TSHR (0.41) TDP1MAPTMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6201119-B1 2,3,4,5-TETRAHYDRO-1H-1,4-BENZODIAZEPIN-9-AMINE COMPOUNDS USEFUL AS INTERMEDIATES TO ANTIVIRALS JANSSEN PHARMACEUTICA N.V. (BE) 2001-03-13 US disclosed
EP-0417840-B1 Antiviral tetrahydroimidazo [1,4]-benzodiazepines JANSSEN PHARMACEUTICA NV (BE) 1994-12-07 EP disclosed
US-5371079-A Administering to inhibit replication of HIV-1 in human cells JANSSEN PHARMACEUTICA N.V. (BE) 1994-12-06 US disclosed
US-5270464-A Anti-HIV-1 tetrahydroimidazo[1,4]benzodiazepin-2-(thi) ones JANSSEN PHARMACEUTICA N.V. (BE) 1993-12-14 US disclosed
EP-0491751-A1 ANTIVIRAL TETRAHYDROIMIDAZO 1,4]BENZODIAZEPINES JANSSEN PHARMACEUTICA N.V. (BE) 1992-07-01 EP disclosed
WO-1991004255-A1 ANTIVIRAL TETRAHYDROIMIDAZO[1,4]BENZODIAZEPINES JANSSEN PHARMACEUTICA N.V. (BE) 1991-04-04 WO disclosed